Home > Research > Publications & Outputs > Genotyping the future
View graph of relations

Genotyping the future: scientists' expectations about race/ethnicity after BiDil

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Published

Standard

Genotyping the future: scientists' expectations about race/ethnicity after BiDil. / Tutton, Richard; Smart, Andrew; Martin, Paul A. et al.
In: Journal of Law, Medicine and Ethics, Vol. 36, No. 3, 09.2008, p. 464-470.

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Harvard

Tutton, R, Smart, A, Martin, PA, Ashcroft, R & Ellison, GTH 2008, 'Genotyping the future: scientists' expectations about race/ethnicity after BiDil', Journal of Law, Medicine and Ethics, vol. 36, no. 3, pp. 464-470. https://doi.org/10.1111/j.1748-720X.2008.292.x

APA

Tutton, R., Smart, A., Martin, P. A., Ashcroft, R., & Ellison, G. T. H. (2008). Genotyping the future: scientists' expectations about race/ethnicity after BiDil. Journal of Law, Medicine and Ethics, 36(3), 464-470. https://doi.org/10.1111/j.1748-720X.2008.292.x

Vancouver

Tutton R, Smart A, Martin PA, Ashcroft R, Ellison GTH. Genotyping the future: scientists' expectations about race/ethnicity after BiDil. Journal of Law, Medicine and Ethics. 2008 Sept;36(3):464-470. doi: 10.1111/j.1748-720X.2008.292.x

Author

Tutton, Richard ; Smart, Andrew ; Martin, Paul A. et al. / Genotyping the future : scientists' expectations about race/ethnicity after BiDil. In: Journal of Law, Medicine and Ethics. 2008 ; Vol. 36, No. 3. pp. 464-470.

Bibtex

@article{db774a2cedd2413489f039a2b17ee24b,
title = "Genotyping the future: scientists' expectations about race/ethnicity after BiDil",
abstract = "The ongoing debate about the FDA approval of BiDil in 2005 demonstrates how the first racially/ethnically licensed drug is entangled in both Utopian and dystopian future visions about the continued saliency of race/ethnicity in science and medicine. Drawing on the sociology of expectations, this paper analyzes how scientists in the field of pharmacogenetics are constructing certain visions of the future with respect to the use of social categories of race/ethnicity and the impact of high-throughput genotyping technologies that promise to transform scientific practices.",
keywords = "RACE, PHARMACOGENETICS, ETHNICITY, GENETICS, MEDICINE, SCIENCE, DRUGS",
author = "Richard Tutton and Andrew Smart and Martin, {Paul A.} and Richard Ashcroft and Ellison, {George T. H.}",
year = "2008",
month = sep,
doi = "10.1111/j.1748-720X.2008.292.x",
language = "English",
volume = "36",
pages = "464--470",
journal = "Journal of Law, Medicine and Ethics",
issn = "1073-1105",
publisher = "Wiley-Blackwell",
number = "3",

}

RIS

TY - JOUR

T1 - Genotyping the future

T2 - scientists' expectations about race/ethnicity after BiDil

AU - Tutton, Richard

AU - Smart, Andrew

AU - Martin, Paul A.

AU - Ashcroft, Richard

AU - Ellison, George T. H.

PY - 2008/9

Y1 - 2008/9

N2 - The ongoing debate about the FDA approval of BiDil in 2005 demonstrates how the first racially/ethnically licensed drug is entangled in both Utopian and dystopian future visions about the continued saliency of race/ethnicity in science and medicine. Drawing on the sociology of expectations, this paper analyzes how scientists in the field of pharmacogenetics are constructing certain visions of the future with respect to the use of social categories of race/ethnicity and the impact of high-throughput genotyping technologies that promise to transform scientific practices.

AB - The ongoing debate about the FDA approval of BiDil in 2005 demonstrates how the first racially/ethnically licensed drug is entangled in both Utopian and dystopian future visions about the continued saliency of race/ethnicity in science and medicine. Drawing on the sociology of expectations, this paper analyzes how scientists in the field of pharmacogenetics are constructing certain visions of the future with respect to the use of social categories of race/ethnicity and the impact of high-throughput genotyping technologies that promise to transform scientific practices.

KW - RACE

KW - PHARMACOGENETICS

KW - ETHNICITY

KW - GENETICS

KW - MEDICINE

KW - SCIENCE

KW - DRUGS

U2 - 10.1111/j.1748-720X.2008.292.x

DO - 10.1111/j.1748-720X.2008.292.x

M3 - Journal article

VL - 36

SP - 464

EP - 470

JO - Journal of Law, Medicine and Ethics

JF - Journal of Law, Medicine and Ethics

SN - 1073-1105

IS - 3

ER -